These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16895657)

  • 1. New approaches to the therapy of HSV infections.
    Whitley R
    Herpes; 2006 Aug; 13(2):53-5. PubMed ID: 16895657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of common cutaneous herpes simplex virus infections.
    Emmert DH
    Am Fam Physician; 2000 Mar; 61(6):1697-706, 1708. PubMed ID: 10750877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial.
    Schacker T; Hu HL; Koelle DM; Zeh J; Saltzman R; Boon R; Shaughnessy M; Barnum G; Corey L
    Ann Intern Med; 1998 Jan; 128(1):21-8. PubMed ID: 9424977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Famciclovir as antiviral prophylaxis in laser resurfacing procedures.
    Wall SH; Ramey SJ; Wall F
    Plast Reconstr Surg; 1999 Sep; 104(4):1103-8; discussion 1109. PubMed ID: 10654754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose famciclovir for the treatment of herpes labialis.
    Hull C; Spruance S; Tyring S; Hamed K
    Curr Med Res Opin; 2006 Sep; 22(9):1699-702. PubMed ID: 16968573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Famciclovir for the treatment of recurrent genital and labial herpes lesions.
    Langley RG
    Skin Therapy Lett; 2005 Dec-2006 Jan; 10(10):5-7. PubMed ID: 16408140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus prophylaxis with famciclovir in patients undergoing aesthetic facial CO2 laser resurfacing.
    Bisaccia E; Scarborough D
    Cutis; 2003 Oct; 72(4):327-8. PubMed ID: 14604087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group.
    Sacks SL; Aoki FY; Diaz-Mitoma F; Sellors J; Shafran SD
    JAMA; 1996 Jul; 276(1):44-9. PubMed ID: 8667538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group.
    Romanowski B; Aoki FY; Martel AY; Lavender EA; Parsons JE; Saltzman RL
    AIDS; 2000 Jun; 14(9):1211-7. PubMed ID: 10894286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Famciclovir prophylaxis of herpes simplex virus reactivation after laser skin resurfacing.
    Alster TS; Nanni CA
    Dermatol Surg; 1999 Mar; 25(3):242-6. PubMed ID: 10193975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of famciclovir on herpes simplex virus type 1 corneal disease and establishment of latency in rabbits.
    Loutsch JM; Sainz B; Marquart ME; Zheng X; Kesavan P; Higaki S; Hill JM; Tal-Singer R
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2044-53. PubMed ID: 11408221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Famciclovir reduces viral mucosal shedding in HSV-seropositive persons.
    Leone P; Warren T; Hamed K; Fife K; Wald A
    Sex Transm Dis; 2007 Nov; 34(11):900-7. PubMed ID: 17538513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.
    Wald A; Selke S; Warren T; Aoki FY; Sacks S; Diaz-Mitoma F; Corey L
    Sex Transm Dis; 2006 Sep; 33(9):529-33. PubMed ID: 16540883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose, patient-initiated famciclovir: a randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis.
    Spruance SL; Bodsworth N; Resnick H; Conant M; Oeuvray C; Gao J; Hamed K
    J Am Acad Dermatol; 2006 Jul; 55(1):47-53. PubMed ID: 16781291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial.
    Aoki FY; Tyring S; Diaz-Mitoma F; Gross G; Gao J; Hamed K
    Clin Infect Dis; 2006 Jan; 42(1):8-13. PubMed ID: 16323085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Famciclovir safe and effective for herpes.
    AIDS Patient Care STDS; 1997 Oct; 11(5):375. PubMed ID: 11361826
    [No Abstract]   [Full Text] [Related]  

  • 17. Famciclovir treatment options for patients with frequent outbreaks of recurrent genital herpes: the RELIEF trial.
    Bartlett BL; Tyring SK; Fife K; Gnann JW; Hadala JT; Kianifard F; Berber E
    J Clin Virol; 2008 Oct; 43(2):190-5. PubMed ID: 18621575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group.
    Mertz GJ; Loveless MO; Levin MJ; Kraus SJ; Fowler SL; Goade D; Tyring SK
    Arch Intern Med; 1997 Feb; 157(3):343-9. PubMed ID: 9040303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The continuing evolution of antiviral therapy for recurrent genital herpes: 1-day patient-initiated treatment with famciclovir.
    Aoki FY
    Herpes; 2007 Dec; 14(3):62-5. PubMed ID: 18371288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The helicase primase inhibitor, BAY 57-1293 shows potent therapeutic antiviral activity superior to famciclovir in BALB/c mice infected with herpes simplex virus type 1.
    Biswas S; Jennens L; Field HJ
    Antiviral Res; 2007 Jul; 75(1):30-5. PubMed ID: 17175035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.